Hairy cell leukemia: a successful model for experimental therapeutics—pentostatin and new ideas

References

• Bouroncle BA, Wiseman BK, Doan CA. Leukemic reticuloendotheliosis. Blood 1958;13:609–630.
   PubMed Web of Science ®Google Scholar
• Frassoldati A, Lamparelli T, Federico M, Hairy cell leukemia: a clinical review based on 725 cases of the Italian Cooperative Group (ICGHCL). Italian Cooperative Group for Hairy Cell Leukemia. Leuk Lymphoma 1994;13: 307–316.
   PubMed Web of Science ®Google Scholar
• Quesada JR, Reuben J, Manning JT, Alpha interferon for induction of remission in hairy-cell leukemia. N Engl J Med 1984;310:15–18.
   PubMed Web of Science ®Google Scholar
• Giblett ER, Anderson JE, Cohen F, Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 1972;2:1067–1069.
   PubMed Web of Science ®Google Scholar
• Fischer D, Van der Weyden MB, Snyderman R, A role for adenosine deaminase in human monocyte maturation. J Clin Invest 1976;58:399–407.
   PubMed Web of Science ®Google Scholar
• Grever MR, Siaw MF, Coleman MS, Inhibition of K and NK lymphocyte cytotoxicity by an inhibitor of adenosine deaminase and deoxyadenosine. J Immunol 1983;130:365–369.
   PubMed Web of Science ®Google Scholar
• Grever MR, Siaw MF, Jacob WF, The biochemical and clinical consequences of 2′-deoxycoformycin in refractory lymphoproliferative malignancy. Blood 1981;57:406–417.
   PubMed Web of Science ®Google Scholar
• Grever MR, Leiby JM, Kraut EH, Low-dose deoxycoformycin in lymphoid malignancy. J Clin Oncol 1985;3:1196–1201.
   PubMed Web of Science ®Google Scholar
• Kraut EH, Bouroncle BA, Grever MR. Low-dose deoxycoformycin in the treatment of hairy cell leukemia. Blood 1986;68:1119–1122.
   PubMed Web of Science ®Google Scholar
• Grever M, Kopecky K, Foucar MK, Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study. J Clin Oncol 1995;13:974–982.
   PubMed Web of Science ®Google Scholar
• Kraut EH, Bouroncle BA, Grever MR. Pentostatin in the treatment of advanced hairy cell leukemia. J Clin Oncol 1989;7:168–172.
   PubMed Web of Science ®Google Scholar
• Grever MR. How I treat hairy cell leukemia. Blood 2010;115:21–28.
   PubMed Web of Science ®Google Scholar
• Johnston JB, Eisenhauer E, Corbett WE, Efficacy of 2′-deoxycoformycin in hairy-cell leukemia: a study of the National Cancer Institute of Canada Clinical Trials Group. J Natl Cancer Inst 1988;80:765–769.
   PubMed Web of Science ®Google Scholar
• Maloisel F, Benboubker L, Gardembas M, Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients. Leukemia 2003;17:45–51.
   PubMed Web of Science ®Google Scholar
• Piro LD, Carrera CJ, Carson DA, Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med 1990;322:1117–1121.
   PubMed Web of Science ®Google Scholar
• Goodman GR, Burian C, Koziol JA, Extended follow-up of patients with hairy cell leukemia after treatment with cladribine. J Clin Oncol 2003;21:891–896.
   PubMed Web of Science ®Google Scholar
• Chadha P, Rademaker AW, Mendiratta P, Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience. Blood 2005;106:241–246.
   PubMed Web of Science ®Google Scholar
• Golomb HM. Hairy cell leukemia: treatment successes in the past 25 years. J Clin Oncol 2008;26:2607–2609.
   PubMed Web of Science ®Google Scholar
• Lauria F, Bocchia M, Marotta G, Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications. Haematologica 1999;84:22–25.
   PubMed Web of Science ®Google Scholar
• Zenhausern R, Schmitz SF, Solenthaler M, Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98). Leuk Lymphoma 2009;50: 1501–1511.
   PubMed Web of Science ®Google Scholar
• Zinzani PL, Tani M, Marchi E, Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine. Haematologica 2004;89:309–313.
   PubMed Web of Science ®Google Scholar
• Grever MR, Zinzani PL. Long-term follow-up studies in hairy cell leukemia. Leuk Lymphoma 2009;50(Suppl. 1):23–26.
   PubMed Web of Science ®Google Scholar
• Thomas DA, Ravandi F, Keating M, Importance of minimal residual disease in hairy cell leukemia: monoclonal antibodies as a therapeutic strategy. Leuk Lymphoma 2009;50(Suppl. 1):27–31.
   PubMed Web of Science ®Google Scholar
• Flinn IW, Kopecky KJ, Foucar MK, Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin. Blood 2000;96:2981–2986.
   PubMed Web of Science ®Google Scholar
• Else M, Dearden CE, Matutes E, Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis. Br J Haematol 2009;145:733–740.
   PubMed Web of Science ®Google Scholar
• Lucas DM, Edwards RB, Lozanski G, The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo. Blood 2009;113:4656–4666.
   PubMed Web of Science ®Google Scholar
• Byrd JC, Lin TS, Dalton JT, Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia. Blood 2007;109:399–404.
   PubMed Web of Science ®Google Scholar
• Lauria F, Forconi F. Combination therapies to improve the long-term outcome in hairy cell leukemia. Leuk Lymphoma 2009;50(Suppl. 1):18–22.
   PubMed Web of Science ®Google Scholar
• Kreitman RJ, Stetler-Stevenson M, Margulies I, Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia. J Clin Oncol 2009;27: 2983–2990.
   PubMed Web of Science ®Google Scholar
• Kreitman RJ, Fitzgerald DJ, Pastan I. Approach to the patient after relapse of hairy cell leukemia. Leuk Lymphoma 2009;50(Suppl. 1):32–37.
   PubMed Web of Science ®Google Scholar